:

ACCEL RAISES $5B FOR LATE-STAGE STARTUPS

AI DESK1 MIN READ
WED, APR 15, 2026

Venture capital firm Accel closed a $5B fundraising round, bringing its assets under management to $36B. The new capital includes a $4B Leaders fund for large checks to late-stage startups globally and a $650M sidecar fund.

Accel's latest raise reflects growing investor appetite for backing mature private companies. The $4B Leaders fund targets late-stage startups worldwide, enabling larger check sizes as companies extend their private fundraising timelines. The $650M sidecar fund allows Accel's existing investors additional opportunities to participate in select investments, a common structure among mega-fund managers. Accel has backed AI companies including Anthropic, Cursor, and Perplexity, positioning itself at the center of the generative AI investment boom. The firm's expanded capital base signals confidence in its ability to deploy across multiple growth stages and geographies. The fundraising adds Accel to a growing list of venture firms raising massive funds for late-stage investments, as traditional IPO and M&A exit windows narrow for private companies.

■ MORE FROM THE STARTUPS DESK

Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.

YESTERDAYAI Desk

Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.

YESTERDAYAI Desk

Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.

YESTERDAYAI Desk

H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.

YESTERDAYIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.